candoxatril has been researched along with Cardiomegaly in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Casley, DJ; Johnston, CI; Yasujima, M; Yoshida, K | 1 |
Ikuse, T; Kuro, T; Matsumura, Y; Nose, M; Okahara, A | 1 |
2 other study(ies) available for candoxatril and Cardiomegaly
Article | Year |
---|---|
Effect of chronic neutral endopeptidase inhibition on cardiac hypertrophy after experimental myocardial infarction.
Topics: Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Cardiomegaly; Drug Evaluation, Preclinical; Hemodynamics; Indans; Kidney; Male; Myocardial Infarction; Myocardium; Neprilysin; Propionates; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Ventricular Remodeling | 1998 |
Effects of SA7060, a novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme, on deoxycorticosterone acetate-salt-induced hypertension in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Blood Pressure; Body Weight; Cardiomegaly; Desoxycorticosterone; Enalapril; Heart; Hypertension; Hypertrophy; Indans; Kidney; Kidney Function Tests; Male; Naphthalenes; Neprilysin; Organ Size; Peptidyl-Dipeptidase A; Propionates; Rats; Rats, Sprague-Dawley; Urea | 2000 |